# Nuvectis Pharma, Inc.: Form S-1, filed Aug 15, 2022

- Company: [Nuvectis Pharma, Inc.](/companies/nvct.md) (CIK 1875558)
- Form: S-1
- Filed: 2022-08-15
- Accepted by EDGAR: Aug 15, 2022, 09:09 ET
- Period: not reported
- Accession: 0001104659-22-090692
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1875558/000110465922090692/tm2223302d1_s1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1875558/000110465922090692/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1875558/000110465922090692/tm2223302d1_s1.htm

Filed Aug 15, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-090692. Last ingested by Listed: Nov 4, 2026, 08:08 ET. No prices; not investment advice.
